ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselAmyra Biotech AG
Amyra Biotech AG Logo
Verified· 2 sources

Amyra Biotech AG

Summary

About the company

The core activity of AMYRA Biotech is the development and research of Brush Border Enzyme Supplementation Technology (BBEST), particularly for the treatment of general health and nutrition issues, food intolerances and gastrointestinal diseases through the supplementation of enzymes found in the small intestine mucosa.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Brush Border Enzyme Supplementation Technology (BBEST)
Technology for supplementing brush border enzymes in the small intestine, to support digestion, nutrient absorption and gastrointestinal health; includes consumer healthcare and pharmaceutical applications.
AMYNOPEP
Enzyme combination for rapid release in the small intestine, for breaking down hard-to-digest protein fragments including gluten, and to support digestion and amino acid uptake.
Consumer healthcare products for digestion
Products for general health and nutrition as well as for food intolerances, developed to support intestinal digestive function within the BBEST pipeline.
Prescription medicines for digestion
Pharmaceutical products for intestinal digestion in gastrointestinal diseases, developed within the BBEST pipeline for clinical and preclinical applications.

Knowledge

No knowledge articles yet

Once Amyra Biotech AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Amyra Biotech AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Amyra Biotech AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Amyra Biotech AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 9
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-321.956.288
Founded
2013 · 13 years
Last commercial register change
July 14, 2026
Employees
1 to 10

Similar companies

SA
SpiroChem AG
Basel
SA
Scailyte AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel